Guyasuta Investment Advisors’s Guardant Health GH Stock Holding History

Guyasuta Investment Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$647K	Hold	7,000	–	–	0.04%	155
2025 Q4	$715K	Buy	7,000 +260	+4%	+$23.3K	0.04%	142
2025 Q3	$421K	Hold	6,740	–	–	0.02%	180
2025 Q2	$351K	Hold	6,740	–	–	0.02%	189
2025 Q1	$287K	Hold	6,740	–	–	0.02%	205
2024 Q4	$206K	Buy	+6,740	New	+$190K	0.01%	258
2023 Q3	–	Sell	-6,240	Closed	-$223K	–	236
2023 Q2	$223K	Buy	+6,240	New	+$179K	0.02%	229
2022 Q4	–	Sell	-6,240	Closed	-$336K	–	238
2022 Q3	$336K	Hold	6,240	–	–	0.03%	170
2022 Q2	$252K	Hold	6,240	–	–	0.02%	230
2022 Q1	$413K	Hold	6,240	–	–	0.03%	200
2021 Q4	$624K	Hold	6,240	–	–	0.04%	171
2021 Q3	$780K	Hold	6,240	–	–	0.06%	145
2021 Q2	$775K	Hold	6,240	–	–	0.06%	147
2021 Q1	$953K	Hold	6,240	–	–	0.07%	132
2020 Q4	$804K	Hold	6,240	–	–	0.07%	134
2020 Q3	$698K	Hold	6,240	–	–	0.06%	126
2020 Q2	$506K	Hold	6,240	–	–	0.05%	144
2020 Q1	$434K	Hold	6,240	–	–	0.05%	135
2019 Q4	$488K	Hold	6,240	–	–	0.05%	149
2019 Q3	$398K	Hold	6,240	–	–	0.04%	152
2019 Q2	$539K	Buy	+6,240	New	+$477K	0.06%	138

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guyasuta Investment Advisors's GH Position: Q1 2026 in Review

Guyasuta Investment Advisors held its Guardant Health (GH) position steady in Q1 2026 at 7,000 shares worth $647K. The position accounts for 0.04% of the portfolio, ranked #155.

Guyasuta Investment Advisors first reported a position in GH in Q2 2019 and has held it in 21 quarters since. The position peaked at $953K in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Guyasuta Investment Advisors held 7,000 shares of Guardant Health worth $647K as of Q1 2026.
Guyasuta Investment Advisors left its Guardant Health share count unchanged in Q1 2026.
Guardant Health made up 0.04% of Guyasuta Investment Advisors's portfolio in Q1 2026, its #155 holding.
Guyasuta Investment Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 21 quarters since.
Guyasuta Investment Advisors's Guardant Health position peaked at $953K in Q1 2021.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.